Published on March 16, 2010 at 9:09 AM
Research and Markets (http://www.researchandmarkets.com/research/851ba8/glaucoma_pharmaceu) has announced the addition of the "Glaucoma Pharmaceuticals - Global Strategic Business Report" report to their offering.
“Glaucoma Pharmaceuticals - Global Strategic Business Report”
This report analyzes the Global market for Glaucoma Pharmaceuticals in US$ Million.
The report provides separate comprehensive analytics for US, and Rest of World.
Annual forecasts are provided for the period 2006 through 2015.
The report profiles 32 companies including many key and niche players worldwide such as:
- Acadia Pharmaceuticals, Inc.
- Alcon Laboratories, Inc.
- Allergan, Inc.
- Falcon Pharmaceuticals, Ltd.
- Inotek Pharmaceuticals Corporation
- Inspire Pharmaceuticals, Inc.
- Lexicon Pharmaceuticals, Inc.
- Merck & Co., Inc.
- NicOx S.A
- Novartis International AG
- Pfizer, Inc.
- Santen Pharmaceutical Co., Ltd.
Market data and analytics are derived from primary and secondary research.
For information on site licence pricing please click on Enquire before buying
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. Executive Summary
1. GLOBAL OUTLOOK
2. AN OVERVIEW OF GLAUCOMA DISORDER
3. AN OVERVIEW OF GLAUCOMA TREATMENT
4. SELECT NEW DRUG APPROVALS
5. RECENT INDUSTRY ACTIVITY
6. FOCUS ON SELECT GLOBAL PLAYERS
7. GLOBAL MARKET PERSPECTIVE
III. MARKET
1. UNITED STATES
2. REST OF WORLD
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 32 (including Divisions/Subsidiaries - 33)
Region/Country Players
The United States 20
Canada 1
Japan 4
Europe 7
France 3
Rest of Europe 4
Middle East 1
http://www.researchandmarkets.com/research/851ba8/glaucoma_pharmaceu